Search

Search Constraints

You searched for: Author/Creator Reiser, Jochen

Search Results

2. BDNF repairs podocyte damage by microRNA‐mediated increase of actin polymerization. Issue 5 (7th January 2015)

3. Cell Cycle Biomarkers and Soluble Urokinase-Type Plasminogen Activator Receptor for the Prediction of Sepsis-Induced Acute Kidney Injury Requiring Renal Replacement Therapy: A Prospective, Exploratory Study. Issue 12 (December 2019)

4. Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes. (September 2017)

5. Comparison of Aptamer-Based and Antibody-Based Assays for Protein Quantification in Chronic Kidney Disease. Issue 3 (March 2022)

6. C‐Kit+ Cells Isolated from Developing Kidneys Are a Novel Population of Stem Cells with Regenerative Potential1. (23rd August 2013)

7. Evaluation of a fast‐and‐frugal clinical decision algorithm ('pathways') on clinical outcomes in hospitalised patients with COVID‐19 treated with anticoagulants. Issue 1 (13th October 2022)

8. FC 043SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) DETERMINES OUTCOMES IN CLINICAL AND EXPERIMENTAL SEPTIC ACUTE KIDNEY INJURY. (29th May 2021)

9. Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial. Issue 11 (11th November 2022)

10. Induction of Long-Lasting Regulatory B Lymphocytes by Modified Immune Cells in Kidney Transplant Recipients. Issue 1 (22nd January 2023)